Vaxcyte (FRA:5VA) Beginning Cash Position : €366.67 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Vaxcyte Beginning Cash Position?

Vaxcyte's Beginning Cash Position for the quarter that ended in Mar. 2024 was €366.67 Mil.

Vaxcyte's quarterly Beginning Cash Position increased from Sep. 2023 (€498.39 Mil) to Dec. 2023 (€500.90 Mil) but then declined from Dec. 2023 (€500.90 Mil) to Mar. 2024 (€366.67 Mil).

Vaxcyte's annual Beginning Cash Position declined from Dec. 2021 (€341.79 Mil) to Dec. 2022 (€65.95 Mil) but then increased from Dec. 2022 (€65.95 Mil) to Dec. 2023 (€766.18 Mil).

Vaxcyte Beginning Cash Position Historical Data

The historical data trend for Vaxcyte's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxcyte Beginning Cash Position Chart

Vaxcyte Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

59.48

48.48

341.79

65.95

766.18

Vaxcyte Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															780.38	351.96	498.39	500.90	366.67

Vaxcyte Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Vaxcyte Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Vaxcyte's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxcyte (FRA:5VA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxcyte Inc (FRA:5VA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

PCVX:USA

Address

825 Industrial Road, Suite 300, San Carlos, CA, USA, 94070

Website

https://www.vaxcyte.com

Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-XP, VAX-A1, and VAX-PG.

Vaxcyte (FRA:5VA) Headlines

No Headlines